Candida auris: An emerging multidrug-resistant pathogen

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
David Sears, Brian S Schwartz

Abstract

Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.

Citations

Feb 17, 2018·Frontiers in Immunology·Juan TangJian Zhang
Dec 6, 2018·Acta Clinica Belgica·Klaas DewaeleKatrien Lagrou
Jan 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohammad H SemreenAshraf S Ibrahim
May 14, 2019·The Journal of Antimicrobial Chemotherapy·Catiana DudiukGuillermo Garcia-Effron
May 23, 2019·Journal of Occupational and Environmental Hygiene·Steven R TorresMagdia De Jesus
Feb 19, 2019·Mycoses·Shabir A Lone, Aijaz Ahmad
Jun 12, 2019·Antimicrobial Agents and Chemotherapy·Kohei YamashitaHiroshi Mukae
Jun 7, 2019·Current Genetics·Lucian DuvenageCampbell W Gourlay
Nov 3, 2018·Journal of Fungi·Olufunmilola MakanjuolaSamuel A Fayemiwo
May 7, 2020·Antibiotics·Martyna Mroczyńska, Anna Brillowska-Dąbrowska
Jun 21, 2019·BMC Infectious Diseases·Caroline MasloJennifer Coetzee
May 28, 2019·Mycoses·Rachna SinghShivaprakash M Rudramurthy
Jul 6, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Marwan OsmanMonzer Hamze
Sep 8, 2018·Home Healthcare Now·Sonya L Kowalski, Christen K Kemp
Jan 1, 2019·Critical Care Research and Practice·Ashlesha Kaushik, Helen Kest
Mar 6, 2019·Frontiers in Cellular and Infection Microbiology·Mansoureh VatanshenassanMarkus Kostrzewa
Jan 27, 2020·Mycopathologia·Harsimran KaurShivaprakash M Rudramurthy
Apr 20, 2019·Frontiers in Cellular and Infection Microbiology·Haroldo Cesar de OliveiraOscar Zaragoza
May 28, 2019·Medical Mycology·Fruzsina NagyRenátó Kovács
Apr 4, 2019·Frontiers in Microbiology·Eugenio ManceraRichard J Bennett
Oct 31, 2018·Journal of Fungi·Ronnie G Willaert
Oct 18, 2018·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Jaroslava DekkerováHelena Bujdáková
Oct 14, 2020·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E Elcocks, E C Adukwu
Oct 20, 2020·Frontiers in Bioengineering and Biotechnology·Kevin S FarquharDaniel A Charlebois
Jan 25, 2021·American Journal of Infection Control·Eric J EckboMarthe Charles
Jan 21, 2019·Biochemical Pharmacology·Madhura KulkarniJ Marie Hardwick
Apr 14, 2021·Microbial Pathogenesis·Nahid AkhtarM Amin-Ul Mannan
Mar 10, 2019·Biochimica Et Biophysica Acta. Proteins and Proteomics·Brian C MonkMikhail V Keniya

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The American Journal of Nursing
Betsy Todd
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Cecilia Tapia, Christian Batarce
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Jennie JohnstoneProvincial Infectious Diseases Advisory Committee – Infection Prevention and Control (PIDAC-IPC)
© 2021 Meta ULC. All rights reserved